The precision medicine market is continuously adding new tools to expand capabilities across translational research, clinical applications, as well as therapeutic development and innovation. With spatial omics imaging expanding upon single cell profiling, we believe that adoption of this technology could accelerate from academic laboratories and into the broader life sciences ecosystem - if it continues to prove its worth, and systems become more automated and cheaper
- Spatial omics imaging is a new modality of cellular analysis that has long been overlooked for single cell profiling. However, the scientific community has realized that a holistic approach combining an understanding of single cells spatially within the tissue microenvironment is a more effective tool than single cell analysis alone.
- Spatial omics imaging is a high capital investment technology, so utilization is currently limited mostly to academic research labs and medical centers that receive grant funding due to their access to tissue samples.
- As competitors in the spatial omics imaging market improve their platforms, and academia continues to build upon publications demonstrating its utility, spatial omics is expected to see additional penetration into healthcare and biopharma markets as tools for both advanced diagnostics and drug discovery.
- Indeed, secondary research indicates that the global spatial omics market is expected to grow from $210M in 2021 to $476M in 2026, a ~18% CAGR (see Figure 1, below).
Figure 1: Size and growth of the global spatial omics market by application and end user
Global Spatial Omics Market by Application ($M)
Global Spatial Omics Market by End User ($M)